Nicaise Claude
- SEC CIK
- 0001644162
No open-market purchases or sales filed in the past year.
Current role at each company
- GANX Gain Therapeutics, Inc.Directoras of Jul 17, 2026
- SRPT Sarepta Therapeutics, Inc.Directoras of Jun 5, 2026
- FLNA Filana Therapeutics, Inc.Directoras of May 27, 2025
- CMMB Chemomab Therapeutics Ltd.Directoras of Mar 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nicaise Claude as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRPT Sarepta Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 (view filing) | Mar 12 | 1 day | Nicaise ClaudeDirector | SSale | −2.49K | $99.64 | −$248.2K | −8.2%27.8K after |